Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)

Jiangxi Sanxin Medtec Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,582	1,497	1,296	1,334	1,164	938.21
Other Revenue	3.85	3.85	3.66	2.38	-	2.17
Revenue	1,586	1,500	1,300	1,336	1,164	940.39
Revenue Growth (YoY)	9.18%	15.41%	-2.69%	14.75%	23.81%	30.31%
Cost of Revenue	1,022	972.05	847.27	886.52	763.96	636.23
Gross Profit	563.75	528.39	452.79	449.49	400.33	304.15
Selling, General & Admin	198.76	192.01	169.71	193.43	158.38	129.66
Research & Development	70.14	63.98	51.07	40.85	42.15	29.49
Other Operating Expenses	15.38	5.15	10.28	10.24	11.12	8.74
Operating Expenses	286.84	265.17	231.9	245.57	213.34	167.21
Operating Income	276.9	263.21	220.89	203.91	186.98	136.94
Interest Expense	-1.88	-3.11	-4.52	-2.95	-2.08	-1.45
Interest & Investment Income	14.79	12.44	16.01	5.71	2.13	2.06
Currency Exchange Gain (Loss)	2.92	2.92	0.76	1.57	1.78	0.82
Other Non Operating Income (Expenses)	-0.38	-0.23	-1.15	-1.09	-4.62	0.03
EBT Excluding Unusual Items	292.36	275.24	231.98	207.16	184.19	138.4
Gain (Loss) on Sale of Investments	-16.64	-11.02	1.3	1.17	-0.46	0.09
Gain (Loss) on Sale of Assets	-0.26	0.19	0.16	0.01	-0.89	0.01
Asset Writedown	-1.81	-1.1	-0.38	-6.71	-3.22	-4.12
Other Unusual Items	28.37	12.75	19.71	23.99	15.76	19.27
Pretax Income	302.02	276.06	252.77	225.61	195.37	153.66
Income Tax Expense	33.35	28.36	29.54	26.52	23.56	24.67
Earnings From Continuing Operations	268.67	247.7	223.23	199.1	171.81	128.99
Minority Interest in Earnings	-24.2	-20.3	-16.6	-14.46	-15.9	-13.36
Net Income	244.47	227.4	206.63	184.63	155.91	115.62
Net Income to Common	244.47	227.4	206.63	184.63	155.91	115.62
Net Income Growth	4.86%	10.05%	11.92%	18.42%	34.84%	87.45%
Shares Outstanding (Basic)	514	515	518	515	507	503
Shares Outstanding (Diluted)	518	516	519	515	513	516
Shares Change (YoY)	-0.53%	-0.53%	0.71%	0.35%	-0.53%	-1.38%
EPS (Basic)	0.48	0.44	0.40	0.36	0.31	0.23
EPS (Diluted)	0.47	0.44	0.40	0.36	0.30	0.22
EPS Growth	5.42%	10.64%	11.13%	18.00%	35.56%	90.08%
Free Cash Flow	140.46	172.05	52.34	191.62	154.91	174.76
Free Cash Flow Per Share	0.27	0.33	0.10	0.37	0.30	0.34
Dividend Per Share	0.300	0.300	0.115	0.115	0.115	0.102
Dividend Growth	39.28%	159.97%	-	-	12.58%	99.80%
Gross Margin	35.55%	35.22%	34.83%	33.64%	34.38%	32.34%
Operating Margin	17.46%	17.54%	16.99%	15.26%	16.06%	14.56%
Profit Margin	15.42%	15.16%	15.89%	13.82%	13.39%	12.29%
Free Cash Flow Margin	8.86%	11.47%	4.03%	14.34%	13.31%	18.58%
EBITDA	378.27	352.32	293.65	267.06	242.54	186.78
EBITDA Margin	23.86%	23.48%	22.59%	19.99%	20.83%	19.86%
D&A For EBITDA	101.37	89.11	72.76	63.14	55.55	49.84
EBIT	276.9	263.21	220.89	203.91	186.98	136.94
EBIT Margin	17.46%	17.54%	16.99%	15.26%	16.06%	14.56%
Effective Tax Rate	11.04%	10.27%	11.68%	11.75%	12.06%	16.05%
Revenue as Reported	1,586	1,500	1,300	1,336	1,164	940.39
Advertising Expenses	-	7.52	1.97	4.66	8.16	4.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.